Dyne Therapeutics Inc IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Dyne Therapeutics Inc | DYN - NASDAQ |
$16.00-$18.00 | $19.00 | $22.59 | 12.25 million | 9/17/2020 |
| J.P. Morgan, Jefferies, Piper Sandler, Stifel | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-08-25 Terms Added 2020-09-10 | ||||||
Dyne Therapeutics Inc Quote & Chart - Click for current quote - DYN
IPO Boutique aggregates information on public companies and private companies, such as "DYN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Dyne Therapeutics Inc (adapted from Dyne Therapeutics Inc prospectus):
They are building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "DYN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.